Both are effective GLP-1 medications for weight loss, but they work slightly differently: The Bottom Line: Both medications are excellent options
The main drivers for weight regain after significant WL include the persistence of a lower resting metabolic rate and the increased appetite, possibly mediated through long lasting increased orexigenic and decreased anorexigenic signals [2, 6]
One of the most critical barriers to health during the pandemic has been consumer access to reliable, science-based, culturally appropriate, and native language information resources, which the partnership will facilitate
Doctors report that GLP-1 medications, originally approved for obesity and diabetes, are increasingly being used to help women with Polycystic Ovary Syndrome (PCOS) a hormonal disorder often tied to weight gain, insulin resistance, and fertility issues
The rise of GLP-1 medications such as semaglutide and tirzepatide has changed how many people approach weight management and overall health
